Hemin clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses Hemin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 20 Jul 1983 · Panhematin · BLA 101246 (FDA, Purple Book)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
The University of Texas Medical Branch, Galveston (2) · Mayo Clinic (2) · Erasme University Hospital (1) · Rush University Medical Center (1)
Studies
Open first, then newest update. How each study uses Hemin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Panhematin for Prevention of Acute Attacks of PorphyriaTerminatedPhase 2The University of Texas Medical Branch, GalvestonNCT02922413Written as Hemin for injection
- Controlled Trial of Panhematin in Treatment of Acute Attacks of PorphyriaCompletedPhase 2The University of Texas Medical Branch, GalvestonNCT02180412Written as Panhematin
- Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute PancreatitisCompletedPhase 2Erasme University HospitalNCT01855841Written as Hemin
- A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)CompletedPhase 2Mayo ClinicNCT01206582Written as Hemin
- Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDSTerminatedPhase 2Rush University Medical CenterNCT00467610Written as Panhematin
- Hemin in Healthy SubjectsCompletedPhase 1Mayo ClinicNCT00882804Written as Hemin infusion
Codes
What other systems call Hemin · ClinicalTrials.gg INT007601
- MeSH (NLM) D006427HeminConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 743LRP9S7NHEMINOne source NLM
- RxNorm 5175One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D006427 | Hemin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 743LRP9S7N | HEMIN | One source NLM |
| RxNorm | 5175 | — | One source FDA |
Also registered as hematin (UNII 0WP180G15G).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.